Infinity Pharma (INFI) Tops Q2 EPS by 22c

Infinity Pharma (NASDAQ: INFI) reported Q2 EPS of ($0.78), $0.22 better than the analyst estimate of ($1.00). Revenue for the quarter came in at $4.9 million versus the consensus estimate of $5.83 million.

For earnings history and earnings-related data on Infinity Pharma (INFI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c